Pangia Biotech
Delray Beach, US · Founded 2023 · Florida corporation
Founders & leadership
JF
Joseph FrattaroliExecutive
OP
Obdulio PilotoExecutive
CP
Caroline PopperExecutive
HM
Holly MagliochettiExecutive
Board
GL
Garth Lees-RolfeBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2026
▶$1.6MraisedMay 2026 · 18 investors · BiotechnologyRule 506(c)
▶$1.6MraisedMay 2026 · 18 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Joseph FrattaroliExecutive Officer
- Obdulio PilotoExecutive Officer
- Garth Lees-RolfeDirector
- Caroline PopperExecutive Officer
- Holly MagliochettiExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $30K
- Sales commissions
- $168K
- Placement agents
- WestPark Capital, Inc.
- First sale
- Apr 2026
- Incorporated
- Corporation, Florida, 2023
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pangia Biotech raised?
- Pangia Biotech has disclosed $1.6M raised across 1 round.
- Where is Pangia Biotech headquartered?
- Pangia Biotech is headquartered in Delray Beach, US.